Edwards Lifesciences Corp (EW)
85.61
+0.36
(+0.42%)
USD |
NYSE |
May 06, 09:55
Edwards Lifesciences Enterprise Value: 50.34B for May 3, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 50.34B |
| May 02, 2024 | 50.23B |
| May 01, 2024 | 49.77B |
| April 30, 2024 | 49.99B |
| April 29, 2024 | 50.76B |
| April 26, 2024 | 51.05B |
| April 25, 2024 | 52.00B |
| April 24, 2024 | 52.35B |
| April 23, 2024 | 51.83B |
| April 22, 2024 | 51.35B |
| April 19, 2024 | 50.74B |
| April 18, 2024 | 51.05B |
| April 17, 2024 | 51.52B |
| April 16, 2024 | 53.21B |
| April 15, 2024 | 52.70B |
| April 12, 2024 | 53.35B |
| April 11, 2024 | 54.03B |
| April 10, 2024 | 54.09B |
| April 09, 2024 | 55.02B |
| April 08, 2024 | 54.59B |
| April 05, 2024 | 54.81B |
| April 04, 2024 | 53.91B |
| April 03, 2024 | 55.00B |
| April 02, 2024 | 55.78B |
| April 01, 2024 | 55.74B |
| Date | Value |
|---|---|
| March 31, 2024 | 56.53B |
| March 28, 2024 | 56.54B |
| March 27, 2024 | 56.30B |
| March 26, 2024 | 55.25B |
| March 25, 2024 | 55.10B |
| March 22, 2024 | 55.48B |
| March 21, 2024 | 56.01B |
| March 20, 2024 | 55.03B |
| March 19, 2024 | 55.79B |
| March 18, 2024 | 54.91B |
| March 15, 2024 | 54.59B |
| March 14, 2024 | 55.22B |
| March 13, 2024 | 54.96B |
| March 12, 2024 | 53.74B |
| March 11, 2024 | 53.69B |
| March 08, 2024 | 54.48B |
| March 07, 2024 | 55.43B |
| March 06, 2024 | 52.13B |
| March 05, 2024 | 50.79B |
| March 04, 2024 | 51.34B |
| March 01, 2024 | 50.26B |
| February 29, 2024 | 50.05B |
| February 28, 2024 | 50.73B |
| February 27, 2024 | 51.04B |
| February 26, 2024 | 50.82B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
31.68B
Minimum
Mar 23 2020
80.39B
Maximum
Dec 30 2021
52.44B
Average
50.27B
Median
Enterprise Value Benchmarks
| Stryker Corp | 135.58B |
| Align Technology Inc | 20.77B |
| Abbott Laboratories | 191.38B |
| Boston Scientific Corp | 115.63B |
| Steris PLC | 23.66B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 351.90M |
| Revenue (Quarterly) | 1.598B |
| Total Expenses (Quarterly) | 1.160B |
| EPS Diluted (Quarterly) | 0.58 |
| Gross Profit Margin (Quarterly) | 75.87% |
| Profit Margin (Quarterly) | 22.02% |
| Earnings Yield | 2.71% |
| Operating Earnings Yield | 3.33% |
| Normalized Earnings Yield | 3.031 |